Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Computed Tomography | Case report

Classic Kaposi sarcoma in a patient of Miao ethnicity followed up for 7 years: a case report

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

Classic Kaposi sarcoma (CKS) is a vascular sarcoma associated with human herpesvirus 8 (HHV-8), which is known to be more common in Mediterranean elderly men and is characterized by indolent clinical behavior. Xinjiang province in China is considered an endemic region for Kaposi’s sarcoma-associated herpesvirus (KSHV), with higher incidence among adults of Kazak and Uyghur ethnicities. Cases of CKS are rarely reported in inland China. Here, we followed a case of CKS for 7 years in a patient of Miao ethnic background in southwestern China.

Case presentation

A 63-year-old Miao (southwestern China) man was initially diagnosed with CKS in 2010, having a history of limb lesions for 37 years, with left eyelid and binaural lesions for 9 years. He did not have sexual contact with men and was human immunodeficiency virus (HIV)-negative. Due to his lumbago and fever, spinal tuberculosis in the lumbar vertebra was highly suspected after computed tomography (CT) scan. However, diagnostic antituberculosis treatment for 4 weeks failed. The patient was followed up in 2016, when the rash was recovering as the systemic symptoms improved. A new CT was performed, which showed a partial response despite the absence of any medical treatment. The open reading frame (ORF)-K1 of KSHV from skin tissue of the foot was amplified and sequenced, and K1 belonged to subtype A. This genotype is consistent with the typical subtype present in Xinjiang.

Conclusions

We describe spontaneous partial regression of CKS in a patient of Miao ethnicity in inland China. Our sample may represent an unknown, novel genotype. Surveillance and regulating the immune state may represent a valuable approach for this rare disease.
Literature
1.
go back to reference Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–9.CrossRef Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–9.CrossRef
2.
go back to reference Mohanna S, Maco V, Bravo F, Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis. 2005;9(5):239–50.CrossRef Mohanna S, Maco V, Bravo F, Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis. 2005;9(5):239–50.CrossRef
5.
go back to reference Ronquist F, Huelsenbeck JP. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003;19:1572–4.CrossRef Ronquist F, Huelsenbeck JP. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003;19:1572–4.CrossRef
7.
go back to reference Cattelan A, Trevenzoli M, Aversa S. Recent advances in the treatment of AIDS-related Kaposi’s sarcoma. Am J Clin Dermatol. 2002;3(7):451–62.CrossRef Cattelan A, Trevenzoli M, Aversa S. Recent advances in the treatment of AIDS-related Kaposi’s sarcoma. Am J Clin Dermatol. 2002;3(7):451–62.CrossRef
8.
go back to reference Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV. Kaposi’s sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med. 2007;49(3):119–38.PubMed Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV. Kaposi’s sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med. 2007;49(3):119–38.PubMed
9.
go back to reference Brown EE, Whitby D, Vitale F, Marshall V, Mbisa G, Gamache C, et al. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer. 2006;107(9):2282–90.CrossRef Brown EE, Whitby D, Vitale F, Marshall V, Mbisa G, Gamache C, et al. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer. 2006;107(9):2282–90.CrossRef
10.
go back to reference Sung JC, Louie SG, Park SY. Kaposi’s sarcoma: advances in tumor biology and pharmacotherapy. Pharmacotherapy. 1997;17(4):670–83.PubMed Sung JC, Louie SG, Park SY. Kaposi’s sarcoma: advances in tumor biology and pharmacotherapy. Pharmacotherapy. 1997;17(4):670–83.PubMed
11.
go back to reference Galleu A, Fozza C, Simula MP, Contini S, Virdis P, Corda G, et al. CD4+ and CD8+ T-Cell Skewness in classic Kaposi sarcoma. Neoplasia. 2012;14(6):487–94.CrossRef Galleu A, Fozza C, Simula MP, Contini S, Virdis P, Corda G, et al. CD4+ and CD8+ T-Cell Skewness in classic Kaposi sarcoma. Neoplasia. 2012;14(6):487–94.CrossRef
13.
go back to reference Caponetti G, Dezube BJ, Restrepo CS, et al. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer. 2007;109(6):1040–52.CrossRef Caponetti G, Dezube BJ, Restrepo CS, et al. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer. 2007;109(6):1040–52.CrossRef
Metadata
Title
Classic Kaposi sarcoma in a patient of Miao ethnicity followed up for 7 years: a case report
Publication date
01-12-2021

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue